Important note: Information in this article was accurate in 2005. The state of the art may have changed since the publication date.
South African Press Association - December 25, 2005
Emmanuel Coujon
President Olusegun Obasanjo signed off on a health ministry proposal to distribute free anti-retroviral drugs (ARVs) to up to 500 000 HIV/Aids patients from January next year, Abuja announced on Friday.
Africa's most populous country has the world's third-highest number of people with HIV/Aids -- 3,5-million -- after India and South Africa.
The health ministry said the measure is a "Christmas present" to those living with the virus and announced that the monthly contribution of 1 000 nairas ($7) will be waived for patients selected for the programme.
Aids groups in the oil-rich West African nation of 130-million have long pushed for abolition of the fee, arguing many patients could not afford it, leading to gaps in treatment and increasing patient resistance to ARVs.
"That is exactly what we have been asking for a very long time. It is very good for us," said Rolake Odetoyinbo, of the Treatment Access Movement.
The government claimed it will treat 250 000 patients by June 2006, about half of those requiring the drugs, Odetoyinbo said.
Not all people living with HIV need treatment, he added.
"I hope they have considered the issue of supplies and budget. But first of all, the government has to create the right and favourable environment to make sure that free ARV distribution happens," he said.
"They have to include the communities in their strategies and also people living with HIV in the treatment, and to fight stigmatisation of these persons who are unable to take the drugs sometimes."
Femi Soyinka, president of the international Aids conference in the capital, Abuja, in early December, queried whether the government could support a long-term programme.
"My concern is that they give the drugs in the long term to avoid problems of resistance. They must have a plan to sustain it as long as it is needed," he said.
A Nigerian study by health aid organisation Medecins sans Frontieres (MSF) found breaks in treatment led to patients developing resistance to anti-retrovirals, which then required more powerful, costlier drugs.
Patients had to find on average $44 per month for the drugs and tests for plotting the virus's development, MSF said.
The health ministry said $11-million is earmarked for the scheme, part of $1-billion in savings gained through Nigeria's recent debt-relief agreement with the Paris Club of creditor countries.
Foreign companies have been contacted to supply the drugs, the ministry said in a statement on Friday.
"President Obasanjo said the free treatment regime was also to ensure that people living with HIV/Aids enjoy the fruit of the debt forgiveness," the statement said.
The Paris Club on October 20 announced it would cancel $18-billion or 60% of Nigeria's $30-billion debt and voiced strong support for the country's economic development policy and its fight against poverty.
051225
SA051202
Copyright © 2005 - South African Press Association. Reproduction of this article (other than one copy for personal reference) must be cleared through the South African Press Association, Cotswold House, Greenacres Office Park, Cnr. Victory & Rustenburg Roads, VICTORY PARK, PO BOX 7766, JOHANNESBURG, 2000; Fax No: +27 11 782-1587/8, Tel No: +27 11 782-1600.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.
Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .